Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Electrophysiological subtypes and associated prognosis factors of Mexican adults diagnosed with Guillain-Barré syndrome, a single center experience.
López-Hernández JC, Colunga-Lozano LE, Garcia-Trejo S, Gomez-Figueroa E, Delgado-Garcia G, Bazán-Rodríguez L, Cervantes-Uribe R, Burgos-Centeno J, Fernandez-Valverde F, Vargas-Cañas ES. López-Hernández JC, et al. J Clin Neurosci. 2020 Oct;80:292-297. doi: 10.1016/j.jocn.2020.04.059. Epub 2020 Jul 13. J Clin Neurosci. 2020. PMID: 32674942
Cyclophosphamide treatment in active multiple sclerosis.
Gómez-Figueroa E, Gutierrez-Lanz E, Alvarado-Bolaños A, Casallas-Vanegas A, Garcia-Estrada C, Zabala-Angeles I, Cadena-Fernandez A, Veronica RA, Irene TF, Flores-Rivera J. Gómez-Figueroa E, et al. Neurol Sci. 2021 Sep;42(9):3775-3780. doi: 10.1007/s10072-021-05052-1. Epub 2021 Jan 16. Neurol Sci. 2021. PMID: 33452657
Clinical experience of plasmapheresis for neuromyelitis optica patients in Mexico.
Gómez-Figueroa E, Alvarado-Bolaños A, García-Estrada C, Zabala-Ángeles I, Sánchez-Rosales N, Bribiesca-Contreras E, García-Alvarez G, Montes-Pérez Y, Ramos-Vega E, Casallas-Vanegas A, Carrillo-Loza K, Corona-Vázquez T, Rivas-Alonso V, Flores-Rivera J. Gómez-Figueroa E, et al. Mult Scler Relat Disord. 2021 Jul;52:103022. doi: 10.1016/j.msard.2021.103022. Epub 2021 May 15. Mult Scler Relat Disord. 2021. PMID: 34034213
Impact of rituximab in Mexican patients with Multiple Sclerosis-A single-center retrospective study.
Bribiesca-Contreras E, García-Estrada C, Gómez-Figueroa E, Zertuche-Ortuño L, Rodríguez-Rivas R, Marcín-Sierra M, Delgado-Niño M, Rivas-Alonso V, Corona-Vázquez T, Flores-Rivera J. Bribiesca-Contreras E, et al. Among authors: gomez figueroa e. Mult Scler Relat Disord. 2022 Feb;58:103485. doi: 10.1016/j.msard.2021.103485. Epub 2022 Jan 4. Mult Scler Relat Disord. 2022. PMID: 35042092
Rituximab efficacy at different initial and maintenance doses in neuromyelitis optica spectrum disorder: Experience from a national health institute in México.
Casallas-Vanegas A, Gomez-Figueroa E, de Saráchaga AJ, Zabala-Angeles I, García-Estrada C, Salado-Burbano JC, DiazGranados-Palacio MC, Corona-Vázquez T, de Jesús Flores-Rivera J, Rivas-Alonso V. Casallas-Vanegas A, et al. J Neurol Sci. 2020 Dec 15;419:117204. doi: 10.1016/j.jns.2020.117204. Epub 2020 Oct 22. J Neurol Sci. 2020. PMID: 33161302
30 results